Stock Information

Relmada Therapeutics Inc (RLMD)

Relmada Therapeutics Inc logo
Ticker Symbol: RLMD
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $368.16 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.96
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -47.52%

Key Financials

Financial data not available